Nissha Co., Ltd. (TSE:7915) entered into a share purchase agreement to acquire Zonnebodo Pharmaceutical Co., Ltd on November 8, 2019. For the fiscal year ended September 30, 2019, Zonnebodo Pharmaceutical Co., Ltd reported total revenue of approximately ¥1 billion. The transaction is expected to be completed by the end of November 2019. Nissha Co., Ltd. (TSE:7915) completed the acquisition of Zonnebodo Pharmaceutical Co., Ltd on November 25, 2019.